Interview: dsm-firmenich innovates with cannabidiol formulations 28-Nov-2023 By Jonathan Smith The pharmaceutical and nutritional products specialist dsm-firmenich aims to make better formulations of cannabidiol (CBD).
All patients dosed in phase 1 study of cannabinoid receptor 16-Nov-2023 By Liza Laws Oxford Cannabinoid Technologies Holdings plc (OCTP), the pharmaceutical company developing prescription cannabinoid medicines, has announced that all cohorts have been dosed in a phase 1 study of OCT461201.
Interview: Arthur Wakeley, MD of Celadon, the first UK company cleared to make medical cannabis 07-Feb-2023 By Liza Laws As reported on January 17, Celadon Pharmaceuticals Plc was the first company to clear the regulations in the UK to make medical cannabis.
'Tremendous milestone': Celadon Pharma gets UK approval for medical cannabis facility 17-Jan-2023 By Liza Laws Celadon Pharmaceuticals Plc has become the first to clear the regulations to make medical cannabis in the UK.